Advanced Pancreatic Cancer

Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

CT
1 program
1
LM-108 injectionPhase 1/21 trial
Active Trials
NCT06821503Not Yet RecruitingEst. Dec 2028
Arcus Biosciences
1 program
1
AB680Phase 11 trial
Active Trials
NCT04104672Active Not RecruitingEst. May 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Chia Tai TianQing Pharmaceutical GroupLM-108 injection
Arcus BiosciencesAB680

Clinical Trials (2)

Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

Start: Feb 2025Est. completion: Dec 2028
Phase 1/2Not Yet Recruiting

A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies

Start: Nov 2019Est. completion: May 2027
Phase 1Active Not Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space